Crossmark

Type I interferon suppresses tumor growth through activating the STAT3-granzyme B pathway in tumor-infiltrating cytotoxic T lymphocytes

Crossref DOI link: https://doi.org/10.1186/s40425-019-0635-8

Published Online: 2019-06-22

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lu, Chunwan

Klement, John D.

Ibrahim, Mohammed L.

Xiao, Wei

Redd, Priscilla S.

Nayak-Kapoor, Asha

Zhou, Gang

Liu, Kebin https://orcid.org/0000-0003-1965-7240
Funding

Funding for this research was provided by:

National Institutes of Health (CA133085)

U.S. Department of Veterans Affairs (CX001364)
License Information

Text and Data Mining valid from 2019-06-22
More Information

Article History

Received: 28 November 2018

Accepted: 11 June 2019

First Online: 22 June 2019

Ethics approval and consent to participate

: No applicable.

: Not Applicable.

: The authors declare that they have no competing interests.